Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...

Reading is one of the most beneficial habits that should be cultivated for our personal growth, intellectual development, and ...

According to Report Ocean, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at a CAGR of ~$% between 2022-2028 owing to rise in cases of UTIs, technological advancements ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Below is a roundup of payer-centric news headlines you may have missed during the month of January 2025. | You may have ...

Quantitative Medicaid managed care network adequacy standards were not associated with improved mental health (MH) care access among adults and those with MH conditions.

Everyone, regardless of income, needs health care to survive and thrive, and most Americans agree that health care is a ...

The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, reflecting ...

The global companion animal diagnostics market is projected to reach US$ 4.55 Billion by 2029 from US$ 2.99 Billion in 2024 ...

The National Eligibility cum Entrance Test (NEET) is a competitive medical entrance examination in India for admission to ...